Category:
Prophylactic Biological Products
CAS NO:
2023788-19-2
Standard:
In-house Standards,
Tirzepatide is a dual GIP and GLP-1 receptor agonist synthesized via Fmoc solid-phase peptide synthesis. Its molecular formula is C226H348N60O69, with CAS number 2117395-82-3.
Contraindicated in patients with personal or family history of medullary thyroid carcinoma. Store lyophilized powder at -20°C; reconstituted solutions require refrigeration at 2-8°C to maintain stability.